Kelyniam Global Expands Offerings with Exclusive Biomaterial License
Kelyniam Global, Inc. (OTC: KLYG), a pioneer in cranial and craniofacial implant solutions, has made a significant advancement by securing an exclusive license from Evonik Industries AG to market VESTAKEEP Fusion, an innovative bi-calcium phosphate-infused PEEK material for use in cranial and maxillofacial implants.
Driving Growth in Innovative Medical Solutions
This exclusive agreement is set for two years and allows Kelyniam the option for renewal by mutual consent. Incorporating VESTAKEEP Fusion strengthens Kelyniam's regenerative product range, capitalizing on its osteoconductive properties that encourage human bone growth. This partnership with Modern Plastics, a trusted supplier of PEEK materials, ensures Kelyniam has reliable access to a proven product as they continue to innovate in neurosurgical applications.
The Significance of VESTAKEEP Fusion
The introduction of VESTAKEEP Fusion represents an essential development for Kelyniam's strategic vision. This cutting-edge material is specifically designed to aid in bone regeneration, making it a crucial asset in advancing their product offerings. The ability to foster natural bone integration is a game-changer, enhancing the functionality of cranial implants while prioritizing patient care.
Enhancing Value for Shareholders
With this licensing agreement, Kelyniam is set to enhance the value for its shareholders by broadening its regenerative medicine portfolio. VESTAKEEP Fusion will sit alongside established options like Finceramica's CustomizedBone and Osteopore's polycaprolactone products. This broadening of offerings positions Kelyniam favorably to meet the growing demand for innovative cranial reconstruction solutions.
Quotes from Leadership
Desiree Webb, Chief Operating and Revenue Officer at Kelyniam Global, expressed her enthusiasm about this new addition: "We’re excited to present VESTAKEEP Fusion as a key component of our innovative cranial and craniofacial product range. Pre-clinical studies indicate that this PEEK-based biomaterial displays remarkable osteointegration, reinforcing our commitment to delivering effective regenerative technologies that enhance patient outcomes."
About Kelyniam Global, Inc.
Kelyniam Global, Inc. (OTC: KLYG) is committed to designing and delivering custom cranial and craniofacial implants using sophisticated biocompatible materials. The company is recognized for its industry-leading delivery times, ensuring that surgeons and hospitals have timely access to essential medical solutions. Kelyniam aims to optimize clinical results while minimizing surgical costs, making strides in the neurosurgery field.
Continued Commitment to Innovation
The team's dedication to innovation in cranial implants underscores their mission to improve healthcare outcomes for patients. As Kelyniam moves forward with the VESTAKEEP Fusion line, they continue to advocate for advanced medical technologies that focus on patient-centric solutions.
Frequently Asked Questions
What is VESTAKEEP Fusion?
VESTAKEEP Fusion is a bi-calcium phosphate-infused PEEK material designed for use in cranial and craniofacial implants, promoting bone growth and integration.
How does Kelyniam Global impact the healthcare industry?
Kelyniam Global provides innovative cranial and craniofacial implants, enhancing clinical outcomes and reducing costs in neurosurgical care.
Who partners with Kelyniam Global?
Kelyniam Global collaborates with Modern Plastics for reliable access to PEEK materials, ensuring they deliver high-quality products.
What is the goal of this licensing agreement?
The license aims to expand Kelyniam's regenerative product lineup and strengthen its market position in cranial reconstruction.
Contact Information for Kelyniam Global
For more information, Kelyniam Global’s contact is available via phone at (860) 590-3034 or through their email at info@kelyniam.com.
